GSK, Sanofi COVID vaccine effort: Late 2021, companies say
GlaxoSmithKline and Sanofi said they are seeking to improve the shot's effectiveness in older people.
Full Article
GSK, Sanofi COVID vaccine effort: Late 2021, companies say
CBS News
0 shares
1 views
You might like
Related news coverage
COVID-19 dominates 2020 for biotech sector … and everyone else
Proactive Investors
The rumblings of the COVID-19 pandemic began in late 2019, when a coronavirus outbreak ripped through Wuhan in Central China. In..
-
Pompeo says Russia 'pretty clearly' behind cyberattack on US
SeattlePI.com
-
Pompeo says Russia 'pretty clearly' behind cyberattack on US
SeattlePI.com
-
COVID-19 shots will be free, declares Bahrain
Mid-Day
-
Sanofi/GSK announce delay in COVID-19 vaccine after interim results show low immune response in older people
Upworthy
Advertisement
More coverage
GlaxoSmithKline, Sanofi say COVID-19 shot won't be ready until late 2021
Upworthy
GSK and Sanofi, based in London and Paris, respectively, said they were confident of the vaccine’s ultimate success due to..
-
GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.
Business Insider
-
GSK, Sanofi say COVID-19 shot won't be ready until late 2021
SeattlePI.com
-
GSK, Sanofi say COVID-19 shot won't be ready until late 2021
SeattlePI.com
-
Sanofi/GSK announce delay in Covid-19 vaccine project
IndiaTimes